Found: 52
Select item for more details and to access through your institution.
A Review of the Advances in Chronic Obstructive Pulmonary Disease Treatment.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy and safety of the direct switch to indacaterol/glycopyrronium from salmeterol/fluticasone in non‐frequently exacerbating COPD patients: The FLASH randomized controlled trial.
- Published in:
- Respirology, 2018, v. 23, n. 12, p. 1152, doi. 10.1111/resp.13374
- By:
- Publication type:
- Article
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2016, v. 5, n. 4, p. 285, doi. 10.1002/cpdd.245
- By:
- Publication type:
- Article
Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial.
- Published in:
- Drugs in R&D, 2016, v. 16, n. 2, p. 217, doi. 10.1007/s40268-016-0131-2
- By:
- Publication type:
- Article
Gastrointestinal bleeding in a patient on multiple medications including edoxaban.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Morbidity and mortality in a population of patients affected by heart failure and chronic obstructive pulmonary disease: an observational study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Effects of combination therapy indacaterol/glycopyrronium versus tiotropium on moderate to severe COPD: evaluation of impulse oscillometry and exacerbation rate.
- Published in:
- Multidisciplinary Respiratory Medicine, 2017, v. 12, p. 1, doi. 10.1186/s40248-017-0105-4
- By:
- Publication type:
- Article
Indacaterol/Glycopyrronium/Mometasone: A Review in Asthma.
- Published in:
- Drugs, 2021, v. 81, n. 6, p. 709, doi. 10.1007/s40265-021-01518-w
- By:
- Publication type:
- Article
Turning a Molecule into a Medicine: the Development of Indacaterol as a Novel Once-Daily Bronchodilator Treatment for Patients with COPD.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Comparison of Clinical Efficacy and Safety between Indacaterol and Tiotropium in COPD: Meta-Analysis of Randomized Controlled Trials.
- Published in:
- PLoS ONE, 2015, v. 10, n. 3, p. 1, doi. 10.1371/journal.pone.0119948
- By:
- Publication type:
- Article
Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0070784
- By:
- Publication type:
- Article
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis.
- Published in:
- Respiratory Research, 2013, v. 14, n. 10, p. 1, doi. 10.1186/1465-9921-14-100
- By:
- Publication type:
- Article
Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium.
- Published in:
- Respiratory Research, 2012, v. 13, n. 6, p. 1, doi. 10.1186/1465-9921-13-52
- By:
- Publication type:
- Article
Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
- Published in:
- Respiratory Research, 2012, v. 13, n. 3, p. 1, doi. 10.1186/1465-9921-13-28
- By:
- Publication type:
- Article
Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis.
- Published in:
- Respiratory Research, 2011, v. 12, n. 12, p. 1, doi. 10.1186/1465-9921-12-161
- By:
- Publication type:
- Article
Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Safety and Efficacy of 12-Week or Longer Indacaterol Treatment in Moderate-to-Severe COPD Patients: A Systematic Review.
- Published in:
- Lung, 2013, v. 191, n. 2, p. 135, doi. 10.1007/s00408-012-9444-2
- By:
- Publication type:
- Article
Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Interactions between glycopyrronium and indacaterol on cholinergic neurotransmission and contractile response in bovine trachealis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of glycopyrronium and indacaterol, as monotherapy and in combination, on the methacholine dose-response curve of mild asthmatics: a randomized three-way crossover study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-62644-1
- By:
- Publication type:
- Article
LABA/LAMA versus LABA/ICS fixed-dose combinations in the prevention of COPD exacerbations: a modeling analysis of literature aggregate data.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 10, p. 1321, doi. 10.1007/s00228-023-03543-y
- By:
- Publication type:
- Article
Efficacy of osteopathic treatment in patients with stable moderate-to-severe chronic obstructive pulmonary disease: a randomized controlled pilot study.
- Published in:
- Journal of Complementary & Integrative Medicine, 2020, v. 17, n. 1, p. 1, doi. 10.1515/jcim-2018-0128
- By:
- Publication type:
- Article
The Beta-2-Adrenoreceptor Agonists, Formoterol and Indacaterol, but Not Salbutamol, Effectively Suppress the Reactivity of Human Neutrophils In Vitro.
- Published in:
- Mediators of Inflammation, 2014, v. 2014, p. 1, doi. 10.1155/2014/105420
- By:
- Publication type:
- Article
COPD 3.
- Published in:
- Respirology, 2017, v. 22, p. 47, doi. 10.1111/resp.13206_17
- Publication type:
- Article
Computed tomography assessment of airway dimensions with combined tiotropium and indacaterol therapy in COPD patients.
- Published in:
- Respirology, 2014, v. 19, n. 3, p. 403, doi. 10.1111/resp.12256
- By:
- Publication type:
- Article
Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: A 26-week Asia- Pacific study.
- Published in:
- Respirology, 2014, v. 19, n. 2, p. 231, doi. 10.1111/resp.12211
- By:
- Publication type:
- Article
2‐D4: COPD 9.
- Published in:
- 2013
- Publication type:
- Abstract
1‐E1: COPD 2.
- Published in:
- 2013
- Publication type:
- Abstract
1‐D4: COPD 1.
- Published in:
- 2013
- Publication type:
- Abstract
OS17: COPD 2.
- Published in:
- 2013
- Publication type:
- Abstract
OS17: COPD 2.
- Published in:
- Respirology, 2013, v. 18, p. 29, doi. 10.1111/resp.12183_17
- Publication type:
- Article
2-D1: COPD 6.
- Published in:
- Respirology, 2013, v. 18, p. 176, doi. 10.1111/resp.12184_36
- Publication type:
- Article
1-E1: COPD 2.
- Published in:
- Respirology, 2013, v. 18, p. 126, doi. 10.1111/resp.12184_18
- Publication type:
- Article
OS14: COPD 1.
- Published in:
- Respirology, 2013, v. 18, p. 23, doi. 10.1111/resp.12183_14
- Publication type:
- Article
2-D4: COPD 9.
- Published in:
- Respirology, 2013, v. 18, p. 183, doi. 10.1111/resp.12184_39
- Publication type:
- Article
Bronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.
- Published in:
- Clinical & Experimental Allergy, 2017, v. 47, n. 10, p. 1239, doi. 10.1111/cea.12972
- By:
- Publication type:
- Article
New Product Focus.
- Published in:
- South African Pharmaceutical Journal, 2014, v. 81, n. 7, p. 26
- Publication type:
- Article
Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.
- Published in:
- Brazilian Journal of Pulmonology / Jornal Brasileiro de Pneumologia, 2016, v. 42, n. 5, p. 367, doi. 10.1590/S1806-37562015000000334
- By:
- Publication type:
- Article
Indacaterol/Glycopyrronium Combination for COPD.
- Published in:
- Pulmonary Therapy, 2017, v. 3, n. 1, p. 45, doi. 10.1007/s41030-016-0024-0
- By:
- Publication type:
- Article
When Two Drugs Are Better than Three: Re-Modulating the Therapeutic Plan of a Chronic Obstructive Pulmonary Disease Patient.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Indacaterol/Glycopyrronium in Clinical Practice: The Italian Experience.
- Published in:
- Respiration, 2018, v. 95, p. 1, doi. 10.1159/000486881
- By:
- Publication type:
- Article
Combination Therapy of Inhaled Indacaterol/Glycopyrronium for Chronic Obstructive Pulmonary Disease in the Very Elderly: Is It Safe? An Electrocardiographic Evaluation.
- Published in:
- Respiration, 2018, v. 95, p. 22, doi. 10.1159/000487182
- By:
- Publication type:
- Article
Indacaterol/Glycopyrronium in the Treatment of Severe Respiratory Failure: Marked Improvement of Respiratory Failure in a Few Weeks – A Case Report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study